Cocrystals of Baicalein with Higher Solubility and Enhanced Bioavailability
Source abstract
Abstract
Baicalein ( Bai ) is one of the most important bioactive flavonoids isolated from the well-known traditional Chinese medicine called “Huang Qin”. Though it has broad therapeutic capability, the bioavailability is limited due to its poor solubility. In this study, we aimed to modulate its solubility through cocrystallization. Cocrystals of Bai with isoniazide ( Inia ), isonicotinamide ( Inam ), caffeine ( Caf ), and theophylline ( Tph ) were obtained. And different cocrystallization methods lead to different cocrystal phases for Inam and Tph . These cocrystals were characterized using powder X-ray diffraction, thermogravimetric analysis, differential scanning calorimetry, dynamic vapor sorption, and Fourier transform infrared spectroscopy. Among all the cocrystals studied, BaiCaf is found to be superior in powder dissolution and pharmacokinetic behavior. Area under the curve values of BaiCaf is improved by a factor of 4.1, and the bioavailability of baicalein is thus expected to be accordingly increased. Given that Caf is a central nervous system stimulant available in many prescription and nonprescription medications, BaiCaf can be a promising alternative solid form of Bai to be developed.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallography and molecular interactions · Molecular spectroscopy and chirality · Crystallization and Solubility Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Pharmaceutical Analytical & Solid-State Chemistry Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China
Funding
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences · Youth Innovation Promotion Association of the Chinese Academy of Sciences · National Natural Science Foundation of China · Chinese Academy of Sciences
References (35)
Show source-provided references
1. 10.1016/j.ctrv.2008.09.00510.1016/j.ctrv.2008.09.005 ↗
2. 10.1111/febs.1296910.1111/febs.12969 ↗
3. 10.3892/mmr.2014.245210.3892/mmr.2014.2452 ↗
4. 10.1055/s-2002-2314310.1055/s-2002-23143 ↗
5. 10.1055/s-2007-97149910.1055/s-2007-971499 ↗
6. 10.1016/j.bbrc.2004.09.09310.1016/j.bbrc.2004.09.093 ↗
7. 10.1016/j.bbrc.2010.07.01510.1016/j.bbrc.2010.07.015 ↗
8. 10.1002/cbic.20100060410.1002/cbic.201000604 ↗
9. 10.1016/j.neulet.2011.01.05510.1016/j.neulet.2011.01.055 ↗
10. 10.1002/jnr.2324410.1002/jnr.23244 ↗
11. Zhang H. · Evid. Based Complement. Alternat. Med. · 2013 · 2013 · 1
12. Harminder · Indian J. Pharm. Sci. · 2011 · 73 · 110.4103/0250-474X.89750 ↗
13. 10.1211/002235705624410.1211/0022357056244 ↗
14. 10.1016/j.ijpharm.2006.01.01110.1016/j.ijpharm.2006.01.011 ↗
15. 10.1208/s12249-010-9560-310.1208/s12249-010-9560-3 ↗
16. 10.1002/jps.2404810.1002/jps.24048 ↗
17. 10.1107/S010827011202445610.1107/S0108270112024456 ↗
18. 10.1021/acs.cgd.5b0085810.1021/acs.cgd.5b00858 ↗
19. 10.1002/jps.2030210.1002/jps.20302 ↗
20. 10.1021/cg300294810.1021/cg3002948 ↗
21. 10.1021/acs.cgd.6b0075910.1021/acs.cgd.6b00759 ↗
22. 10.1021/mp400516b10.1021/mp400516b ↗
23. 10.1021/mp400176y10.1021/mp400176y ↗
24. 10.1021/mp300169c10.1021/mp300169c ↗
25. 10.1021/mp200209j10.1021/mp200209j ↗
26. 10.1021/acs.cgd.6b0059110.1021/acs.cgd.6b00591 ↗
27. 10.1021/acs.cgd.6b0026610.1021/acs.cgd.6b00266 ↗
28. 10.1021/acs.cgd.5b0043910.1021/acs.cgd.5b00439 ↗
29. 10.1021/cg501009c10.1021/cg501009c ↗
30. 10.1039/C4CE01713G10.1039/C4CE01713G ↗
31. 10.1039/c3ce41285g10.1039/c3ce41285g ↗
32. FDA, Guidancefor Industry: Regulatory Classification ofPharmaceutical Co-Crystals. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM516813.pdf.
33. Select Committee on GRAS Substances (SCOGS) Opinion: Caffeine.http://www.fda.gov/food/ingredientspackaginglabeling/gras/scogs/ucm256650.htm.
34. 10.1021/cg200492w10.1021/cg200492w ↗
35. 10.1211/00223570252210.1211/002235702522 ↗